Compare ImmunityBio Inc. Common Stock (IBRX) vs Viavi Solutions Inc. Common Stock (VIAV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ImmunityBio Inc. Common Stock vs Viavi Solutions Inc. Common Stock — how do they compare? ImmunityBio Inc. Common Stock trades at $10.51 (market cap $10.51B), while Viavi Solutions Inc. Common Stock trades at $45.46 (market cap $10.85B). The key difference: ImmunityBio Inc. Common Stock and Viavi Solutions Inc. Common Stock are close in size by market cap, and ImmunityBio Inc. Common Stock is trading nearer its 52-week high, Viavi Solutions Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold ImmunityBio Inc. Common Stock for 1 Days and Viavi Solutions Inc. Common Stock for 1 Days on average.
| IBRX | VIAV | |
|---|---|---|
Market Cap | $10.51B | $10.85B |
Volume | 10,445,785 | 4,281,289 |
Sector | Health | Technology |
52-Week High | $11.55 | $55.33 |
52-Week Low | $1.98 | $12.27 |
Typical Hold Time | 1 Days | 1 Days |
Enterprise Value | $10.97B | $10.89B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ImmunityBio Inc. Common Stock
ImmunityBio develops immune-based therapies for cancer and infectious diseases. Its programs are designed to activate and strengthen the body’s immune response.
Read more on IBRX →About Viavi Solutions Inc. Common Stock
Viavi Solutions provides network testing, monitoring, and optical technologies. Its products help communications providers, equipment makers, and enterprises build and maintain networks.
Read more on VIAV →
